Karnataka Chemists Association Calls for Overhaul of Drugs Control Department

When the Karnataka Chemists Association (KCA) stepped into the spotlight last week, the message was clear: the state's Drugs Control Department (DCD) needs a serious makeover. For years, pharmacists across Karnataka have been wrestling with cumbersome licensing procedures, opaque price‑capping mechanisms and a feeling that their on‑ground insights are barely heard in policy rooms.

“We’re not asking for the moon,” said Dr. Ramesh Sharma, president of the KCA, during a press conference in Bengaluru. “What we need is a system that works with us, not against us.” He went on to outline three core reforms: a streamlined, digitised licensing process; a transparent and regularly reviewed drug‑price formula; and a formal consultative platform where representatives from the chemist community can weigh in on new regulations.

The current licensing regime, according to many shop owners, is riddled with delays. Applications often sit in queues for months, and follow‑up calls to the department usually end in vague promises. “Last year I waited almost six months for a renewal,” recalled Suma Rao, who runs a small pharmacy in Mysore. “By the time I got the paperwork, the price caps had already shifted, squeezing my margins even more.”

Price controls, while intended to keep essential medicines affordable, have become a double‑edged sword. The KCA argues that the existing formula does not adequately factor in regional cost variations, supply‑chain disruptions or the rising price of raw materials. As a result, many chemists are forced to either sell at a loss or limit the stock of vital drugs, which can affect patient access, especially in rural pockets.

Beyond numbers, the association highlights a deeper issue: lack of dialogue. “Policy decisions are made in a vacuum,” Dr. Sharma noted. “We, the people who dispense medicines daily, have practical insights that could improve safety, efficacy and even cost‑effectiveness.” The KCA proposes a quarterly advisory council, co‑chaired by senior officials from the DCD and elected pharmacist representatives, to review emerging challenges and suggest actionable tweaks.

The state government has responded with cautious optimism. A spokesperson from the Department of Health & Family Welfare said, “We welcome constructive feedback and are committed to strengthening Karnataka’s healthcare ecosystem. The suggestions from the KCA will be examined in detail, and we intend to roll out a pilot digital licensing portal by the end of the year.”

Industry observers, however, warn that reform is easier said than done. Implementing a state‑wide digital platform requires robust IT infrastructure, data security safeguards, and training for thousands of pharmacy staff. Moreover, revising price‑control formulas may spark pushback from pharmaceutical manufacturers who argue that any increase could affect their profit margins and, consequently, investment in research.

Still, the consensus among most stakeholders is that the status quo is unsustainable. As Karnataka strives to meet its ambitious health‑care targets under the National Health Mission, ensuring that the frontline dispensers—its chemists—are equipped, fairly compensated, and heard, could make the difference between policy on paper and tangible health outcomes for millions.

For now, the KCA is gearing up for a series of meetings with officials, preparing a detailed white paper, and rallying support from other state chemist associations. Their hope is simple: a more transparent, collaborative, and responsive Drugs Control Department that ultimately serves the people of Karnataka better.